- Evolocumab přidaný ke statinu snižuje riziko kardiovaskulárních příhod2018 | First Faculty of Medicine
- Interakce kouření a diabetu a riziko kardiovaskulárních příhod - komentář ke studii a základní epidemiologická data z České republiky2022 | Second Faculty of Medicine
- Metabolic surgery in prevention and therapy of cardiovascular events2014 | First Faculty of Medicine
- Riziko závažné hypoglykemie je u diabetiků 2. typu vyšší po kardiovaskulární příhodě a naopak2020 | Second Faculty of Medicine
- Chronic renal silure and cardiovascular events2012 | First Faculty of Medicine
- Intenzivní snížení systolického krevního tlaku snižuje výskyt kardiovaskulárních příhod u diabetiků i nediabetiků2018 | First Faculty of Medicine
- Diabetic patient in high risk of cardiovascular events - what to do with him2012 | First Faculty of Medicine
- Interaction between smoking and diabetes and risk of cardiovascular disease2022 | Second Faculty of Medicine
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study2018 | First Faculty of Medicine
- Investigation of cardiovascular disease predispositions by using of PCR at the UKBP FN Motol2011 | Publication without faculty affiliation
- Low-dose aspirin prophylaxis of cardiovascular events in using of nesteroidal antiflogistic mediacation.2003 | First Faculty of Medicine
- Komplexní psychofarmakologický přístup k prevenci kardiovaskulárních příhod u pacientů s ischemickou chorobou srdeční2004 | First Faculty of Medicine
- Residual risk of cardiovascular incidents2009 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. B1481038Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. B1481022 +1Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: B1481022Publication without faculty affiliation
- Is prevention of cardiovascular events a question of the treatment chosen?2012 | First Faculty of Medicine
- Bariatric / metabolic surgery and the effect on cardiovascular events2012 | First Faculty of Medicine
- Prevention of atheroslerotic cardiovascular events in frail patiens2017 | Second Faculty of Medicine
- A step further to lowering of cardiovascular evens in CAD2008 | First Faculty of Medicine
- Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both2010 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no.B1481038Publication without faculty affiliation
- Telmisartan, ramipril, or both in patients at high risk for vascular events2008 | First Faculty of Medicine
- Jak respektují nemocní s obezitou po kardiovaskulární příhodě doporučení ošetřujícího týmu?Publication without faculty affiliation
- Angiotensin converting enzyme inhibitors and angiotensin II AT1 receptor antagonists (sartans) used in the secondary prevention of cardiovascular events, comparison of basic data2010 | Third Faculty of Medicine
- Non-inferiorita kombinace střední dávky statinu a ezetimibu oproti vysokým dávkám statinu při snižování LDL cholesterolu a rizika kardiovaskulárních příhod2023 | First Faculty of Medicine
- Choosing treatment strategy - basic prerequisite for successful prevention of cardiovascular events2012 | First Faculty of Medicine
- What is the relationship of uric acid concentrations and cardiovascular morbidity?2002 | Faculty of Medicine in Hradec Králové
- Využití kyseliny acetylsalicylové v primární prevenci kardiovaskulárních příhod u nemocných s diabetem2021 | First Faculty of Medicine